Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.
It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.
The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
| Country | CR |
| IPO Date | Jul 19, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 908 |
| CEO | Juan Jose Chacon Quiros |
Contact Details
Address: Building B15 and 25 Alajuela, CR | |
| Website | https://www.establishmentlabs.com |
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| Employer ID | 98-1436377 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Juan Jose Chacon Quiros | Founder, Chief Executive Officer & Executive Director |
| Rajbir Singh Denhoy | Chief Financial Officer |
| Roberto de Mezerville | Chief Technology Officer |
| Filippo Caldini | President |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Jeff Ehrhardt | Senior Vice President & GM of North America |
| Neeta Toprani | Corporate Secretary |
| Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical & US Regulatory Affairs |
| S. Ross Mansbach | General Counsel, Chief Compliance Officer & Chief Human Resources Officer |
| Salvador Santos Dada | Head of Special Projects |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 06, 2024 | 4 | Filing |
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 08, 2024 | 424B5 | Filing |
| Nov 07, 2024 | 8-K | Current Report |
| Nov 07, 2024 | 8-K | Current Report |
| Oct 02, 2024 | 4 | Filing |